Renascience Inc. (TYO:4889)
1,557.00
-73.00 (-4.48%)
Jul 15, 2026, 3:30 PM JST
Renascience Market Cap
Renascience has a market cap or net worth of 21.45 billion as of July 15, 2026. Its market cap has decreased by -21.62% in one year.
Market Cap
21.45B
Enterprise Value
18.05B
Revenue
68.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
1,557.00
Market Cap Chart
Since September 24, 2021, Renascience's market cap has increased from 10.13B to 21.45B, an increase of 111.67%. That is a compound annual growth rate of 16.88%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 15, 2026 | 21.45B | 16.65% |
| Dec 30, 2025 | 18.39B | 387.08% |
| Dec 30, 2024 | 3.78B | -31.57% |
| Dec 29, 2023 | 5.52B | 18.26% |
| Dec 30, 2022 | 4.67B | -46.27% |
| Dec 30, 2021 | 8.68B | -14.33% |
| Sep 24, 2021 | 10.13B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cuorips | 38.81B |
| Healios K.K. | 35.64B |
| Japan Tissue Engineering | 26.76B |
| AnGes | 20.34B |
| StemRIM | 18.80B |
| CanBas | 14.47B |
| RaQualia Pharma | 12.63B |
| ReproCELL | 12.26B |